# OnCo record paper-alex-n-engl-j-med-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-alex-n-engl-j-med-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-alex-n-engl-j-med-2017" ;
  schema:name "Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer"@en ;
  schema:description "Published report from the ALEX trial registered as NCT02075840, in New England Journal of Medicine (2017), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-alex-n-engl-j-med-2017/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1704795>, <https://pubmed.ncbi.nlm.nih.gov/28586279/>, <https://europepmc.org/article/MED/28586279>, <https://clinicaltrials.gov/study/NCT02075840> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1704795> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Peters S, Camidge DR, Shaw AT, et al." ;
  onco:trials <https://onco.cc/trials/alex/> ;
  onco:journals <https://onco.cc/journals/nejm/> .